Evotec
- Sandra Muller
Sandra Muller is a Senior Research Scientist and Team Leader in In Vitro Biology at Evotec, overseeing multi-disciplinary Oncology projects from Target Validation to late Lead Optimization since September 2016. Previously, Sandra held roles as a Research Scientist and Research Associate, managing various screening projects in disease areas such as oncology, diabetes, neurodegenerative, and anti-infective diseases. Prior experiences include post-doctoral positions at Etablissement Français du Sang and CNRS, focusing on mesenchymal stem cell properties and adipose tissue dynamics. Sandra earned a PhD in Developmental Neurobiology from Ludwig-Maximilians-Universität München and holds engineering degrees in Life Sciences and Biotechnologies from AgroParisTech.
Org chart
Upgrade to view 0 reports
Offices
This person is not in any offices
Evotec
4 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.
